Breast cancer heterogeneity is the main obstacle preventing the identification of breast cancer patients with poor prognosis and treatment responses, yet such heterogeneity has not been well characterized. The purpose of this retrospective study was to reveal heterogeneous patterns of the apparent diffusion coefficient (ADC) signals in tumours and the surrounding stroma to predict molecular subtypes in breast cancer. A dataset of 126 breast cancer patients who underwent preoperative diffusion-weighted imaging (DWI) on a 3.0-T image system was collected. Breast images were segmented into regions comprising the tumour and surrounding stromal shells in which features that reflect heterogeneous ADC signal distribution were extracted. In each region, imaging features were computed including the mean, minimum, variance, interquartile range (IQR), range, skewness, kurtosis and entropy of ADC values. Univariate and stepwise multivariate logistic regression modelling was performed to identify the MR imaging features that optimally discriminate luminal A, luminal B, HER2-enriched and basallike molecular subtypes. The performance of the predictive models was evaluated using the area under the receiver operating characteristic curve (AUC). Univariate logistic regression analysis showed that the skewness in the tumour boundary achieved an AUC of 0.718 for discriminating between luminal A and non-luminal A tumours, while the interquartile range of the ADC value in the tumour boundary had an AUC of 0.703 for classifying the HER2-enriched subtype. Imaging features in the tumour boundary and the proximal peritumoural stroma corresponded to higher overall prediction performance than those in other regions. A multivariate logistic regression model combining features in all the regions achieved an overall AUC of 0.800 for classifying the four tumour subtypes. These findings suggest that features in the tumour boundary and stroma around the tumour may be further assessed as potential predictors of molecular subtypes of breast cancer.
conducted. The study initially collected 179 patients diagnosed with invasive breast cancer who underwent preoperative DCE-MRI and DWI between January and July 2011. Patients were excluded (n=21) due to the lack of pathological report or incomplete pathology data and no available MRI sequence. Patients who underwent breast cancer treatment (e.g., chemotherapy or radiation therapy, n=32) before MRI were also excluded. Finally, 126 patients who fit the selection criteria were included in our dataset for analysis.
Pathologic Assessment
The expression of ER, PR, HER2 and Ki-67 of each patient with invasive cancer was obtained from pathologic reports by a pathologist using streptavidin-peroxidase (SP) immunohistochemistry (IHC). A sample was scored as ER positive and/or PR positive when at least 1% of the tumour cell nuclei showed staining for ER or PR (30). HER2 status was assessed according to the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines for HER2 testing in breast cancer (31). An IHC HER2 score of 3+ was considered positive, a score of 0 or 1+ was considered negative, and a score of 2+ was further confirmed by fluorescence in situ hybridization (FISH). Tumours with Ki-67 levels greater than 14% were considered high-Ki-67 tumours, and the other tumours were considered low-Ki-67 tumours. Based on the receptor status, the molecular subtype classification was determined, and tumours were categorized as follows: luminal A: ER and/or PR positive, HER2 negative; luminal B: ER and/or PR positive, HER2 positive; HER2-enriched: ER and PR negative, HER2 positive; and basal-like: ER, PR, and HER2 negative. Luminal subtype with a Ki-67 expression level above 14% was specifically assigned to luminal B (1).
MR Image Acquisition
All patients were scanned in the prone position with a Siemens Magnetom Verio 3.0 T MRI scanner (Siemens Medical Solutions, Erlangen, Germany) and a dedicated eightchannel double-breast array coil (Siemens Medical Systems). A precontrast series was To standardize the image analysis as much as possible, a representative ROI was manually drawn around the margin of the tumour on the DWI slice with the largest tumour diameter, and the ROI was then copied to the corresponding ADC map (32) .
Fibroglandular tissue was segmented using a fuzzy C-means clustering procedure on the b=50 image of the DWI, excluding the skin and fatty tissue. The ADC images were manually segmented into the inner tumour, tumour boundary, and the proximal, middle and distal peritumoural stroma shells (Figure 1b, c, d ). Detailed descriptions for these regions are given below.
Feature extraction
In our study, we selected the stromal shell with a 4-pixel width (1.45 mm × 4 pixels=5. For example, the ratio of skewness between the inner tumour (S1) and the tumour boundary (S3) was calculated, which was termed S1/S3-skewness.
Statistical Analysis
Differences in the tumour characteristics were assessed using the χ 2 significance was set at a P value < 0.05. In multiple comparison tests, P values were adjusted using the Bonferroni correction method. Statistical analyses were performed using MATLAB R2014a (MathWorks Inc, Natick, MA, USA). expression. ANOVA revealed a significant association between molecular subtype and Ki-67 expression level (p<0.001) and maximum tumour diameter (p=0.035) ( Table 1) .
Results

Patient clinicopathological characteristics
ADC of the tumour and the stromal shells
In the statistical analysis, one-way ANOVA conducted within each subgroup indicated no significant correlation between ADC values and Ki-67 expression status, histological type or menopausal status (Table 2) . Further analyses were conducted to assess signal patterns of ADC values in the tumour and the surrounding stroma, which are shown in Table 3 . The ADC values in various regions ascended as their distance from the tumour centre increased (Table 3 and Figure 2 ) for all the four subtypes.
HER2-enriched tumours had the highest ADC value among all tumours and stromal shells. One-way ANOVA showed significant differences in the ADC values among the subtypes of breast cancer patients in all regions except for the proximal and distal peritumoural stromal shells. A follow-up post hoc correction for multiple comparisons was carried out to determine significant differences, as shown in Supplementary Table   S1 . The results revealed significant differences in the ADC values between luminal B and HER2-enriched tumours in the inner tumour, the entire tumour and the tumour boundary with corrected p values <0.0001, 0.001 and 0.047, respectively. Supplementary Table S2 . Interestingly, significant differences in the mean ADC values were found between regions with relatively larger distance (i.e., S1 and S5, S1
and S6, S2 and S5, S2 and S6) in luminal A, luminal B and HER2-enriched tumours, while additional significant differences in the mean ADCs were also observed between regions with smaller distances (i.e., S2 and S3, S2 and S4, S3 and S4, S3 and S5) in luminal B tumours. For the basal-like subtype, a significant difference in ADC values was observed only between the inner (S1) and distal (S6) peritumoural stromal shells (corrected p value=0.019).
Univariate analysis to discriminate among breast cancer subtypes
We evaluated the performance of individual imaging features for discriminating among breast cancer subtypes by univariate logistic regression analysis. Table 4 provides the best two individual statistical features and four ratio features for discrimination of the four molecular subtypes. The results suggested that a lower level of skewness of the ADC value in the tumour boundary is more likely to correspond to the luminal A subtype, with an AUC of 0.718, and a 95% confidence interval (CI) from 0.602 to 0.834 (Table 4 and Figure 3 ). Additionally, a higher value of ADC IQR in the tumour boundary is associated with the HER2-enriched subtype, and the univariate logistic regression classifier yielded an AUC of 0.703 with a 95% CI from 0.563 to 0.844 (Table   4 and Figure 3 ). The highest performance among imaging features for discriminating basal-like tumours from other tumour subtypes was the maximum ADC value in the inner tumour region (AUC=0.687, 95% CI from 0.532 to 0.843). Table 4 The Kruskal-Wallis test showed a statistically significant difference in the IQR in the entire tumour among the four molecular subtypes (corrected p=0.0081).
Additionally, the ratio of the IQR between the tumour boundary and the proximal peritumoural stromal shell showed significant differences among the four subtypes with a corrected p=0.0081 (Figure 4 ). The detailed features that were significantly different among the breast subtypes with corrected p value less than 0.05 are listed in Supplementary Table S3 .
Multinomial multivariate logistic regression analysis to classify molecular subtypes
For each region, multivariate stepwise logistic regression analysis was performed to produce the best subset of features to discriminate among the breast subtypes. Table 5 summarizes (Table 5 ).
The statistical features included in the predictive model were the IQR and skewness of ADC in the entire tumour, the skewness in the tumour boundary, the mean and kurtosis of ADC in the proximal stromal shell, and the entropy in the middle stromal shell.
In addition, the ratio features computed between two regions were also combined and exhibited an overall AUC of 0.763 (Table 5 ). The results indicated that the overall performance of the ratio features is comparable to the statistical features in these regions. Table S4 ). Our study had several limitations. First, this study was retrospective in nature, and our patient numbers were relatively small, which could cause some selection bias.
Second, we only focused on the diffusion characteristics of breast cancer and did not evaluate the features of DCE-MRI, which is valuable for discriminating among molecular subtypes in clinical practice (12, 13) . Third, when quantifying DWI regions, we manually drew ROIs on the tumours and peritumoural stromal shells, which may not accurately reflect the characteristics of the breast stroma. Further prospective investigations are needed to validate the clinical usefulness of our work.
In conclusion, DWI parameters, including the ADC, were significantly associated with molecular subtypes in breast cancer. Classification analysis revealed that lower ADC skewness of the tumour boundary was the strongest predictor of luminal A, while the IQR of the ADC value in the tumour boundary was among the best predictors of HER2-enriched tumours. In multiclass classification experiments, the statistical features representing the heterogeneity of the tumour environment are of vital importance for classification. However, further work is needed before these quantitative MRI parameters can be used to non-invasively assess the intrinsic characteristics in breast cancer patients in clinical practice. 21 (17) 2 (1.5)
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